MARKET

XON

XON

Intrexon
NASDAQ

Real-time Quotes | Nasdaq Last Sale

5.83
-0.38
-6.12%
After Hours: 5.83 0 0.00% 17:45 01/17 EST
OPEN
6.24
PREV CLOSE
6.21
HIGH
6.42
LOW
5.78
VOLUME
2.20M
TURNOVER
--
52 WEEK HIGH
9.10
52 WEEK LOW
3.950
MARKET CAP
947.44M
P/E (TTM)
-1.6267
1D
5D
1M
3M
1Y
5Y

Buy or sell shares of XON and other stocks commission-free!

Open a Webull account and fund it to get a free stock

Analyst Rating

Based on 3 analysts

Hold

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

EPS

XON News

  • Triple-Gene Announces Presentation at Upcoming Biotech Showcase Investor Conference
  • PR Newswire.01/09 12:30
  • Intrexon's Blood Cancer Drug Gets Orphan Drug Status From FDA
  • Zacks.01/07 14:51
  • Intrexon will take the name of its subsidiary. That company just scored orphan status for a rare cancer drug.
  • American City Business Journals.01/06 22:14
  • Precigen Receives FDA Orphan Drug Designation for PRGN-3006 UltraCAR-T in Patients with Acute Myeloid Leukemia
  • Benzinga.01/06 12:42

More

Industry

Biotechnology & Medical Research
-0.16%
Pharmaceuticals & Medical Research
+0.06%

Hot Stocks

Name
Price
%Change

About XON

Intrexon Corporation (Intrexon) forms collaborations to create biologically-based products and processes using synthetic biology. The Company's domestic operations are in California, Florida, Maryland, and Virginia, and its primary international operations are in Belgium and Hungary. The Company designs, builds and regulates gene programs, which are deoxyribonucleic acid (DNA) sequences that consist of genetic components. The Company's synthetic biology capabilities include the ability to control the amount, location and modification of biological molecules to control the function and output of living cells and optimize for desired results at an industrial scale. The Company's technologies include UltraVector gene design and fabrication platform, and its associated library of modular DNA components; Cell Systems Informatics; RheoSwitch inducible gene switch; AttSite Recombinases; Protein Engineering; Laser-Enabled Analysis and Processing (LEAP), and ActoBiotics platform.
More

Webull offers Intrexon Corp (XON) stock price, real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, stock news, and many more online research tools to help you make informed decisions.